Behjati, S;
Tarpey, PS;
Haase, K;
Ye, H;
Young, MD;
Alexandrov, LB;
Farndon, SJ;
... Campbell, PJ; + view all
(2017)
Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma.
Nature Communications
, 8
, Article 15936. 10.1038/ncomms15936.
Preview |
Text
Flanagan_ncomms15936.pdf - Published Version Download (2MB) | Preview |
Abstract
Osteosarcoma is a primary malignancy of bone that affects children and adults. Here, we present the largest sequencing study of osteosarcoma to date, comprising 112 childhood and adult tumours encompassing all major histological subtypes. A key finding of our study is the identification of mutations in insulin-like growth factor (IGF) signalling genes in 8/112 (7%) of cases. We validate this observation using fluorescence in situ hybridization (FISH) in an additional 87 osteosarcomas, with IGF1 receptor (IGF1R) amplification observed in 14% of tumours. These findings may inform patient selection in future trials of IGF1R inhibitors in osteosarcoma. Analysing patterns of mutation, we identify distinct rearrangement profiles including a process characterized by chromothripsis and amplification. This process operates recurrently at discrete genomic regions and generates driver mutations. It may represent an age-independent mutational mechanism that contributes to the development of osteosarcoma in children and adults alike.
Type: | Article |
---|---|
Title: | Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1038/ncomms15936 |
Publisher version: | http://dx.doi.org/10.1038/ncomms15936 |
Language: | English |
Additional information: | © The Author(s) 2017. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/ |
Keywords: | Science & Technology, Multidisciplinary Sciences, Science & Technology - Other Topics, Monoclonal-Antibody, Breast-Cancer, Phase-Ii, Growth, Insulin, Signatures, Sarcoma, Amplification, Combination, Landscape |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Pathology |
URI: | https://discovery.ucl.ac.uk/id/eprint/1562188 |
Archive Staff Only
View Item |